Interaction-based discovery of functionally important genes in cancers

Nucleic Acids Research

Volumn 42, Issue 3, 2014, Pages

  Ghersi, Dario ^a   Singh, Mona ^a,b  

^a PRINCETON UNIVERSITY   (United States)

^b Princeton University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; F BOX PROTEIN; FBXW11 PROTEIN; METHYL CPG BINDING PROTEIN; NUCLEIC ACID; PEPTIDE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

AKT1 GENE; AKT3 GENE; ARTICLE; AUTOMATION; BINDING SITE; BREAST CANCER; COLON ADENOCARCINOMA; COMPUTER PROGRAM; DICER1 GENE; ENDOMETRIUM CANCER; EXOME; FBXW11 GENE; FBXW7 GENE; GENE FUNCTION; GENE INTERACTION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GLIOBLASTOMA; HUMAN; INFORMATION PROCESSING; KIDNEY CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MBD1 GENE; MISSENSE MUTATION; ONCOGENE K RAS; OVARY CANCER; PIK3CA GENE; PREDICTION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECTUM CARCINOMA; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; TUMOR SUPPRESSOR GENE;

BETA-TRANSDUCIN REPEAT-CONTAINING PROTEINS; BINDING SITES; DEAD-BOX RNA HELICASES; DNA-BINDING PROTEINS; GENES, NEOPLASM; HUMANS; MUTATION, MISSENSE; NEOPLASMS; POLYMORPHISM, GENETIC; PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RIBONUCLEASE III; SOFTWARE; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 84896739938     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1305     Document Type: Article

References (67)

1. Hudson, T.J., Anderson, W., Artez, A., Barker, A.D., Bell, C., Bernabe, R.R., Bhan, M.K., Calvo, F., Eerola, I., Gerhard, D.S. et al. (2010) International network of cancer genome projects. Nature, 464, 993-998.
2. Barbieri, C.E., Baca, S.C., Lawrence, M.S., Demichelis, F., Blattner, M., Theurillat, J.P., White, T.A., Stojanov, P., Van Allen, E., Stransky, N. et al. (2012) Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet., 44, 685-689.
3. Liang, H., Cheung, L.W., Li, J., Ju, Z., Yu, S., Stemke-Hale, K., Dogruluk, T., Lu, Y., Liu, X., Gu, C. et al. (2012) Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res., 22, 2120-2129.
4. Green, E.D. and Guyer, M.S. (2011) Charting a course for genomic medicine from base pairs to bedside. Nature, 470, 204-213.
5. Garraway, L.A. and Lander, E.S. (2013) Lessons from the cancer genome. Cell, 153, 17-37.
6. Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A. Jr and Kinzler, K.W. (2013) Cancer genome landscapes. Science, 339, 1546-1558.
7. Bozic, I., Antal, T., Ohtsuki, H., Carter, H., Kim, D., Chen, S., Karchin, R., Kinzler, K.W., Vogelstein, B. and Nowak, M.A. (2010) Accumulation of driver and passenger mutations during tumor progression. Proc. Natl Acad. Sci. USA, 107, 18545-18550.
8. Greenman, C., Stephens, P., Smith, R., Dalgliesh, G.L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C. et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature, 446, 153-158.
9. Stratton, M.R., Campbell, P.J. and Futreal, P.A. (2009) The cancer genome. Nature, 458, 719-724.
10. Inda, M.M., Bonavia, R., Mukasa, A., Narita, Y., Sah, D.W., Vandenberg, S., Brennan, C., Johns, T.G., Bachoo, R., Hadwiger, P. et al. (2010) Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev., 24, 1731-1745.
11. Keats, J.J., Chesi, M., Egan, J.B., Garbitt, V.M., Palmer, S.E., Braggio, E., Van Wier, S., Blackburn, P.R., Baker, A.S., Dispenzieri, A. et al. (2012) Clonal competition with alternating dominance in multiple myeloma. Blood, 120, 1067-1076.
12. Kar, G., Gursoy, A. and Keskin, O. (2009) Human cancer protein-protein interaction network: a structural perspective. PLoS Comput. Biol., 5, e1000601.
13. Richardson, C.J., Gao, Q., Mitsopoulous, C., Zvelebil, M., Pearl, L.H. and Pearl, F.M. (2009) MoKCa database-mutations of kinases in cancer. Nucleic Acids Res., 37, D824-D831.
14. Stehr, H., Jang, S.H., Duarte, J.M., Wierling, C., Lehrach, H., Lappe, M. and Lange, B.M. (2011) The structural impact of cancer-Associated missense mutations in oncogenes and tumor suppressors. Mol. Cancer, 10, 54.
15. Nishi, H., Tyagi, M., Teng, S., Shoemaker, B.A., Hashimoto, K., Alexov, E., Wuchty, S. and Panchenko, A.R. (2013) Cancer missense mutations alter binding properties of proteins and their interaction networks. PLoS One, 8, e66273.
16. Sjoblom, T., Jones, S., Wood, L.D., Parsons, D.W., Lin, J., Barber, T.D., Mandelker, D., Leary, R.J., Ptak, J., Silliman, N. et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science, 314, 268-274.
17. Ding, L., Getz, G., Wheeler, D.A., Mardis, E.R., McLellan, M.D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D.M., Morgan, M.B. et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455, 1069-1075.
18. Youn, A. and Simon, R. (2011) Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics, 27, 175-181.
19. Kaminker, J.S., Zhang, Y., Waugh, A., Haverty, P.M., Peters, B., Sebisanovic, D., Stinson, J., Forrest, W.F., Bazan, J.F., Seshagiri, S. et al. (2007) Distinguishing cancer-Associated missense mutations from common polymorphisms. Cancer Res., 67, 465-473.
20. Carter, H., Chen, S., Isik, L., Tyekucheva, S., Velculescu, V.E., Kinzler, K.W., Vogelstein, B. and Karchin, R. (2009) Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res., 69, 6660-6667.
21. Capriotti, E. and Altman, R.B. (2011) A new disease-specific machine learning approach for the prediction of cancer-causing missense variants. Genomics, 98, 310-317.
22. Shihab, H.A., Gough, J., Cooper, D.N., Day, I.N. and Gaunt, T.R. (2013) Predicting the functional consequences of cancer-Associated amino acid substitutions. Bioinformatics, 29, 1504-1510.
23. Ng, P.C. and Henikoff, S. (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res., 31, 3812-3814.
24. Bao, L. and Cui, Y. (2005) Prediction of the phenotypic effects of non-synonymous single nucleotide polymorphisms using structural and evolutionary information. Bioinformatics, 21, 2185-2190.
25. Karchin, R., Diekhans, M., Kelly, L., Thomas, D.J., Pieper, U., Eswar, N., Haussler, D. and Sali, A. (2005) LS-SNP: large-scale annotation of coding non-synonymous SNPs based on multiple information sources. Bioinformatics, 21, 2814-2820.
26. Yue, P. and Moult, J. (2006) Identification and analysis of deleterious human SNPs. J. Mol. Biol., 356, 1263-1274.
27. Wood, L.D., Parsons, D.W., Jones, S., Lin, J., Sjoblom, T., Leary, R.J., Shen, D., Boca, S.M., Barber, T., Ptak, J. et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science, 318, 1108-1113.
28. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S. and Sunyaev, S.R. (2010) A method and server for predicting damaging missense mutations. Nat. Methods, 7, 248-249.
29. Le Calvez-Kelm, F., Lesueur, F., Damiola, F., Vallee, M., Voegele, C., Babikyan, D., Durand, G., Forey, N., McKay-Chopin, S., Robinot, N. et al. (2011) Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study. Breast Cancer Res., 13, R6.
30. Reva, B., Antipin, Y. and Sander, C. (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res., 39, e118.
31. Gonzalez-Perez, A., Deu-Pons, J. and Lopez-Bigas, N. (2012) Improving the prediction of the functional impact of cancer mutations by baseline tolerance transformation. Genome Med., 4, 89.
32. Jonsson, P.F. and Bates, P.A. (2006) Global topological features of cancer proteins in the human interactome. Bioinformatics, 22, 2291-2297.
33. Rambaldi, D., Giorgi, F.M., Capuani, F., Ciliberto, A. and Ciccarelli, F.D. (2008) Low duplicability and network fragility of cancer genes. Trends Genet., 24, 427-430.
34. Ghersi, D. and Singh, M. (2013) Disentangling function from topology to infer the network properties of disease genes. BMC Syst. Biol., 7, 5.
35. Radivojac, P., Baenziger, P.H., Kann, M.G., Mort, M.E., Hahn, M.W. and Mooney, S.D. (2008) Gain and loss of phosphorylation sites in human cancer. Bioinformatics, 24, i241-i247.
36. Reimand, J. and Bader, G.D. (2013) Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers. Mol. Syst. Biol., 9, 637.
37. Nehrt, N.L., Peterson, T.A., Park, D. and Kann, M.G. (2012) Domain landscapes of somatic mutations in cancer. BMC Genomics, 13(Suppl. 4), S9.
38. Hosur, R., Xu, J., Bienkowska, J. and Berger, B. (2011) iWRAP: an interface threading approach with application to prediction of cancer-related protein-protein interactions. J. Mol. Biol., 405, 1295-1310.
39. Cho, D.Y. and Przytycka, T.M. (2013) Dissecting cancer heterogeneity with a probabilistic genotype-phenotype model. Nucleic Acids Res., 41, 8011-8020.
40. Liu, Y., Koyuturk, M., Barnholtz-Sloan, J.S. and Chance, M.R. (2012) Gene interaction enrichment and network analysis to identify dysregulated pathways and their interactions in complex diseases. BMC Syst. Biol., 6, 65.
41. Ng, S., Collisson, E.A., Sokolov, A., Goldstein, T., Gonzalez-Perez, A., Lopez-Bigas, N., Benz, C., Haussler, D. and Stuart, J.M. (2012) PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis. Bioinformatics, 28, i640-i646.
42. Vandin, F., Upfal, E. and Raphael, B.J. (2012) De novo discovery of mutated driver pathways in cancer. Genome Res., 22, 375-385.
43. Sherry, S.T., Ward, M.H., Kholodov, M., Baker, J., Phan, L., Smigielski, E.M. and Sirotkin, K. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res., 29, 308-311.
44. Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N. and Bourne, P.E. (2000) The Protein Data Bank. Nucleic Acids Res., 28, 235-242.
45. Yang, J., Roy, A. and Zhang, Y. (2013) BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions. Nucleic Acids Res., 41, D1096-D1103.
46. Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang, Z., Miller, W. and Lipman, D.J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res., 25, 3389-3402.
47. Sievers, F., Wilm, A., Dineen, D., Gibson, T.J., Karplus, K., Li, W., Lopez, R., McWilliam, H., Remmert, M., Soding, J. et al. (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol., 7, 539.
48. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B Methodol., 57, 289-300.
49. Sommer, S. (2005) The importance of immune gene variability (MHC) in evolutionary ecology and conservation. Front. Zool., 2, 16.
50. Futreal, P.A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. and Stratton, M.R. (2004) A census of human cancer genes. Nat. Rev. Cancer, 4, 177-183.
51. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T. et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25, 25-29.
52. Takeshita, D., Zenno, S., Lee, W.C., Nagata, K., Saigo, K. and Tanokura, M. (2007) Homodimeric structure and double-stranded RNA cleavage activity of the C-terminal RNase III domain of human dicer. J. Mol. Biol., 374, 106-120.
53. Provost, P., Dishart, D., Doucet, J., Frendewey, D., Samuelsson, B. and Radmark, O. (2002) Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J., 21, 5864-5874.
54. Thomas, C.C., Deak, M., Alessi, D.R. and van Aalten, D.M. (2002) High-resolution structure of the pleckstrin homology domain of protein kinase b/akt bound to phosphatidylinositol (3, 4, 5)-trisphosphate. Curr. Biol., 12, 1256-1262.
55. Ohki, I., Shimotake, N., Fujita, N., Jee, J., Ikegami, T., Nakao, M. and Shirakawa, M. (2001) Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell, 105, 487-497.
56. Wu, G., Xu, G., Schulman, B.A., Jeffrey, P.D., Harper, J.W. and Pavletich, N.P. (2003) Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. Mol. Cell, 11, 1445-1456.
57. Kumar, M.S., Lu, J., Mercer, K.L., Golub, T.R. and Jacks, T. (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet., 39, 673-677.
58. Martello, G., Rosato, A., Ferrari, F., Manfrin, A., Cordenonsi, M., Dupont, S., Enzo, E., Guzzardo, V., Rondina, M., Spruce, T. et al. (2010) A MicroRNA targeting dicer for metastasis control. Cell, 141, 1195-1207.
59. Anglesio, M.S., Wang, Y., Yang, W., Senz, J., Wan, A., Heravi-Moussavi, A., Salamanca, C., Maines-Bandiera, S., Huntsman, D.G. and Morin, G.B. (2013) Cancer-Associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage. J. Pathol., 229, 400-409.
60. Santi, S.A. and Lee, H. (2010) The Akt isoforms are present at distinct subcellular locations. Am. J .Physiol. Cell Physiol., 298, C580-C591.
61. Cristiano, B.E., Chan, J.C., Hannan, K.M., Lundie, N.A., Marmy-Conus, N.J., Campbell, I.G., Phillips, W.A., Robbie, M., Hannan, R.D. and Pearson, R.B. (2006) A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition. Cancer Res., 66, 11718-11725.
62. Carpten, J.D., Faber, A.L., Horn, C., Donoho, G.P., Briggs, S.L., Robbins, C.M., Hostetter, G., Boguslawski, S., Moses, T.Y., Savage, S. et al. (2007) A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature, 448, 439-444.
63. Do, H., Salemi, R., Murone, C., Mitchell, P.L. and Dobrovic, A. (2010) Rarity of AKT1 and AKT3 E17K mutations in squamous cell carcinoma of lung. Cell Cycle, 9, 4411-4412.
64. Fujita, N., Takebayashi, S., Okumura, K., Kudo, S., Chiba, T., Saya, H. and Nakao, M. (1999) Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms. Mol. Cell. Biol., 19, 6415-6426.
65. Fuchs, S.Y., Chen, A., Xiong, Y., Pan, Z.Q. and Ronai, Z. (1999) HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin. Oncogene, 18, 2039-2046.
66. Morin, P.J. (1999) beta-catenin signaling and cancer. Bioessays, 21, 1021-1030.
67. Polakis, P. (2000) Wnt signaling and cancer. Genes Dev., 14, 1837-1851.